Gene silencing for HD: the story so far

Gene silencing for HD: the story so far

Is gene silencing as exciting as it sounds for HD, and what might the future hold?

Professor Ed WildMarch 22, 2011

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc

Professor Ed WildMarch 14, 2011

What do sheep brains have to do with HD?

What do sheep brains have to do with HD?

How smart are sheep, and why do HD researchers care?

Dr Jeff CarrollMarch 09, 2011

Interview: CHDI Management

Interview: CHDI Management

HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide

Dr Jeff CarrollFebruary 25, 2011

CHDI Report: Day 3

CHDI Report: Day 3

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

Dr Jeff CarrollFebruary 10, 2011

CHDI Report: Day 2

CHDI Report: Day 2

Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD

Professor Ed WildFebruary 09, 2011

CHDI Report: Day 1

CHDI Report: Day 1

Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene

Dr Jeff CarrollFebruary 08, 2011

Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way

Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way

Anti-nausea drug meclizine protects cells with the HD mutation from death by reducing cellular energy production

Dr Jeff CarrollFebruary 04, 2011

HDBuzz takes your questions to the annual therapeutics meeting of CHDI

HDBuzz takes your questions to the annual therapeutics meeting of CHDI

HDBuzz visits Palm Springs to talk with CHDI about the latest HD research. Send us your questions!

Professor Ed WildJanuary 28, 2011

Welcome to HDBuzz

Welcome to HDBuzz

Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co

Professor Ed WildJanuary 18, 2011

Memantine in HD: dose is everything

Memantine in HD: dose is everything

Memantine, a drug already used in Alzheimer’s disease, might help in HD, but a mouse study shows dose is everything.

Dr Jeff CarrollJanuary 15, 2011

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...